drugset / Trial / NCT01955174

Botulinum Toxin Injection in Hypercontractile Esophagus

NCT01955174

Phase 2 Completed 24 enrolled Hospices Civils de Lyon
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to evaluate the efficacy and the safety of endoscopic injection of 100 IU of botulinum toxin (BTX) in the distal esophagus in patients with symptoms related to hypercontractile esophageal motility disorders.

Timeline

Start
2013-08
Primary completion
2017-05
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin Protein / enzyme biologic 100 iu Other

Indications